Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
207 studies found for:    Open Studies | "Hyperlipidemias"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia
Conditions: Chronic Smokers;   Hyperlipidemia
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: BioTurmin (Curcuma longa rhizomes extract);   Dietary Supplement: BioTurmin-WD (Water dispersible curcuminoids);   Dietary Supplement: MaQxan
2 Unknown  Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia
Conditions: Chronic Smokers;   Hyperlipidemia
Interventions: Other: Placebo;   Dietary Supplement: BioTurmin (Curcuma longa rhizomes extract);   Dietary Supplement: BioTurmin-WD (Water dispersible curcuminoids);   Dietary Supplement: MaQxan (Tagetes erecta flower extract)
3 Not yet recruiting Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dyslipidemia
Condition: Subjects With Hyperlipidemia, Dyslipidemia and HIV Infection
Interventions: Drug: Repatha (Evolocumab);   Drug: Placebo
4 Not yet recruiting Acupuncture and Moxibustion for Hyperlipemia
Condition: Hyperlipidemias
Interventions: Other: acupuncture and moxibustion;   Drug: Simvastatin;   Other: Therapeutic Lifestyle Change
5 Unknown  Effect of Genes on Rosuvastatin Therapy for Hyperlipidemia
Condition: Hyperlipidemia
Interventions: Drug: rosuvastatin,fenofibrate;   Genetic: CYP2C9, UGT1A1, UGT1A3, OATP2, BCRP
6 Recruiting Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia
Condition: Hyperlipidemias
Interventions: Drug: Antroquinonol;   Drug: placebo
7 Unknown  Jiangzhuo Prescription ,Fenofibrate and Placebo in the Treatment of Hyperlipidemia (Syndrome of Phlegm Obstruction)Clinical Study (JZF)
Conditions: Metabolic Syndromes;   Hyperlipidemia
Intervention:
8 Unknown  Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia
Conditions: Hypertension;   Hyperlipidemia
Interventions: Drug: Telmisartan 80mg;   Drug: Rosuvastatin 20mg;   Drug: Rosuvastatin 10mg;   Drug: Placebo(for Telmisartan 80mg);   Drug: Placebo(for Rosuvastatin 20mg);   Drug: Placebo(for Rosuvastatin 10mg)
9 Recruiting Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation
Condition: Hyperlipidemia
Intervention: Drug: TAK-085
10 Unknown  Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients
Conditions: HIV;   Hyperlipidemia;   HIV Infections
Interventions: Drug: ezetimibe;   Drug: fenofibrate;   Drug: pravastatin
11 Recruiting A Double-blind, Randomized Study in Diabetic Subjects With Hyperlipidemia or Mixed Dyslipidemia
Condition: Diabetes, Hyperlipidemia, Mixed Dyslipidemia
Interventions: Biological: Evolocumab (AMG 145);   Drug: Atorvastatin;   Other: Placebo
12 Unknown  Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia
Condition: Hyperlipidemia, Familial Combined
Interventions: Drug: Atorvastatin 20mg;   Drug: Omega-3-acids ethylesters 90 4g;   Other: Placebo(Omega-3-acids ethylesters 90)
13 Unknown  Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid
Condition: Mixed Hyperlipidemia
Interventions: Drug: Atorvastatin 10mg, fenofibric acid 135mg;   Drug: atorvastatin 20mg
14 Unknown  The Clinical Evaluation of Efficacy of Lipid-Lowing Tea on Hyperlipidemia Patients’ Lipid Profiles
Condition: Hyperlipidemia
Intervention: Drug: Lipid-lowing Tea
15 Unknown  Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume
Conditions: Hyperlipidemia;   Coronary Artery Disease
Intervention: Drug: Rosuvastatin
16 Not yet recruiting Effect of Rosuvastatin Therapy on HDL2 Level
Conditions: Hyperlipemia;   Coronary Heart Disease
Interventions: Drug: Rosuvastatin 10mg/d group;   Drug: Rosuvastatin 20mg/d group
17 Recruiting Tele-Pharmacy Intervention to Improve Treatment Adherence
Conditions: Hyperlipidemia;   Diabetes;   Hypertension
Intervention: Behavioral: Telepharmacist intervention
18 Not yet recruiting Nutraceuticals to Improve Lipid Profile in European Countries
Condition: Hyperlipidemia
Interventions: Behavioral: Non-pharmacologic intervention;   Drug: Nutraceuticals (Armolipid Plus)
19 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
20 Unknown  Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients
Condition: Hyperlipidemia
Interventions: Drug: Pitavastatin;   Drug: Atorvastatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years